T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma

Immune checkpoint inhibitors (ICIs) are effective in treating renal cell carcinoma (RCC) but can also cause immune-related adverse events (irAEs). The relationship between irAEs and the T-cell receptor (TCR) repertoire in RCC patients treated with ICIs remains unclear. We analyzed the relationship b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Takuro, Nagata, Masayoshi, Ikehata, Yoshihiro, Nagashima, Yuki, Nagaya, Naoya, Lu, Yan, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670264/
https://www.ncbi.nlm.nih.gov/pubmed/37998738
http://dx.doi.org/10.3390/cimb45110561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670264/
https://www.ncbi.nlm.nih.gov/pubmed/37998738
http://dx.doi.org/10.3390/cimb45110561

Ejemplares similares